1. All Products
  2. DORA - Oral drugs
  3. BECLOMETASONE dipropionate, 50mcg/puff, 200 puffs, aerosol
Public Pricelist

BECLOMETASONE dipropionate, 50mcg/puff, 200 puffs, aerosol

https://medicalguidelines.msf.org/en/node/363
https://unicat.msf.org/cat/product/11911
STD DORABECL5SF

Valid Article

Former Code(s): -X DORABECL5S-
Article is intended to be used with children (<12 years) ONLY.
25.1 - Antiasthmatic medicines and medicines for chronic obstructive pulmonary disease
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
R03BA01
Anatomical Therapeutic Chemical Classification according to WHOCC
UN1950
Hazardous materials and products (identified by their 4-digit transport UN-number) must be transported under certain conditions as specified in the MSDS sheet (Material Safety Data Sheet).
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

BECLOMETASONE dipropionate aerosol

Therapeutic Action

Inhaled corticosteroid (ICS)

Glucocorticoid with an anti-inflammatory action in the lungs, resulting in reduced symptoms and exacerbations of asthma with less adverse effects than with systemic corticosteroids.

Indications

Maintenance treatment of chronic asthma following treatment with inhaled short-acting beta2 agonist (SABA) (salbutamol).

Chronic Obstructive Pulmonary Disease (COPD) following treatment with inhaled salbutamol and salmeterol.

Instructions for use

Suspension or solution in a pressurised metered-dose inhaler (MDI): small canister containing a mixture of medicine and pressurised propellant. The pressure from the propellant delivers the medicine from the canister when the canister is pushed down into the boot/actuator.

Method of administration:

  • Shake the inhaler and ensure that liquid is heard. Remove the mouthpiece cover.
  • Inhale and then exhale as completely as possible.
  • Place the lips firmly around the mouthpiece..
  • Start to inhale with a long, slow breath and continue to breath as deeply as possible when activating the inhaler (puff).
  • Remove the inhaler, close the lips and hold the breath for 10 seconds, or as long as is comfortable.
  • Exhale, wait a few seconds, shake the inhaler again and repeat for the next puff, if required.
  • Replace the mouthpiece cover after use.

Manufacturers may express the content per puff as a "metered dose" (excluding the valve, i.e the quantity of drug substance contained in the device metering chamber) or as a "delivered dose" (excluding the mouthpiece, i.e. the quantity of drug substance delivered to the user). Always consult the product leaflet.

Refer to the information leaflet for appropriate instructions for use/inhalation according the inhaler model.

Pressurised metered-dose inhalers are CFC free presentation. Chlorofluorocarbons (CFCs) are harmful to the ozone layer and HFA (hydrofluoroalkane) propellant is a more effective, and environmentally-friendly alternative.

In adults and adolescents, when beclametasone is used in combination with a short-acting beta2 agonist (SABA), a combination inhaler is available: BECLOMETASONE dipr.100mcg/ FORMOTEROL fum. 6mcg/puff 120p, aer.

Image

Precautions for Use

Beclometasone is not a bronchodilator. For asthma attacks, use inhaled salbutamol.

In children, use an inhalation chamber/spacer with or without a mask (depending on the age of the child) with every administration of pressurised metered dose inhalers.

In patients who have difficulty coordinating the actuation on the metered-dose inhaler and inhalation (e.g elderly patients), use an inhalation chamber/spacer to facilitate administration and improve the effectiveness of the product.

Do not use any mouthpiece other than the one supplied with the inhaler.

Transport Dangerous Goods

UN transport code:

  • UN 1950 - Aerosols, non-flammable (each not exceeding 1 L capacity)
  • Transport Class 2.2 - Non-flammable, non-toxic gases

Transport is only regulated for large quantities of aerosols.

Storage

  • Below 25ºC - Protect from sunlight
  • Used aerosols: do not pierce or incinerate. Empty all residual gas, then bury.
Image